Concepedia

Johannes Flechtenmacher

JF

12

Publications

952

Citations

12

H-Index

1993

Active since

Affiliations

Universität Ulm(Current)

Rush University Medical Center

Presbyterian St. Luke's Medical Center

University of Mannheim

University Hospital Heidelberg

Johannes Flechtenmacher is an author at Universität Ulm specializing in medicine, osteoarthritis, and orthopaedics.

Top concepts

MedicineOsteoarthritisSurgeryImmunologyOrthopedicsRheumatologyHealthAllergyOncologyVirology

Publications per year

1993–2020

12

Publications

12

Recombinant human osteogenic protein 1 is a potent stimulator of the synthesis of cartilage proteoglycans and collagens by human articular chondrocytes

Johannes Flechtenmacher, Klaus Huch, Eugene J.‐M.A. Thonar et al. · Arthritis & Rheumatism · 1996 · 230 citations

Newcastle disease virus-infected intact autologous tumor cell vaccine for adjuvant active specific immunotherapy of resected colorectal carcinoma.

D. Ockert, Volker Schirrmacher, Norman Beck et al. · PubMed · 1996 · 133 citations

Veterinary Vaccine, Immunology, Immunodominance +16

The superficial layer of human articular cartilage is more susceptible to interleukin‐1–induced damage than the deeper layers

Hans Jörg Häuselmann, Johannes Flechtenmacher, Lincoln Michal et al. · Arthritis & Rheumatism · 1996 · 126 citations

Resection for adenocarcinoma of the body and tail of the pancreas

C D Johnson, G. Schwall, Johannes Flechtenmacher et al. · British journal of surgery · 1993 · 103 citations

Pancoast Syndrome, Surgical Oncology, Consecutive Series +12

Effects of recombinant human osteogenic protein 1 on the production of proteoglycan, prostaglandin E<sub>2</sub>, and interleukin‐1 receptor antagonist by human articular chondrocytes cultured in the presence of interleukin‐1β

Klaus Huch, Johannes Flechtenmacher, Berry Wilbrink et al. · Arthritis & Rheumatism · 1997 · 90 citations

Rows per page

1–5 of 12